Title: Drugs Related Changes of Haemoglobin and CD4 Counts in HIV-Infected Patients on Antiretroviral Therapy
Authors: Deebii, N*, Orluwene, CG, Korubo, K. I, and Njoku, B
DOI: http://dx.doi.org/10.18535/jmscr/v3i10.20
The present study examines the effects of antiretroviral therapy (ART) on two basic immuno-haematological parameters over time. We performed a retrospective study of HIV-infected treatment-naïve patients starting a first line ART between June 2014 and January 2015, and followed-up for 12 weeks. On the whole, 254HIV-infected treatment naive patients were enrolled: 100 patients on tenoforvir (TDF) based regimen was compared with 102 and 52 non-TDF based regimen and treatment-naïve patients respectively. Samples were collected at three different points (at baseline, 4 weeks and 12 weeks).CD4 and haemoglobin (Hb) were found to be significantly higher (p=0.001) in the TDF group as compared to non-TDF groups after 12 weeks of follow-up, although there was no significant difference between the Non-TDF group and ART-naive group at 4 and 12 weeks in both parameters. These results demonstrate that the initiation of a TDF based-regimen is followed by an increase in lymphocyte proliferation and lymphocyte-mediated cytotoxicity compared to other non-TDF based-regimen group. However we suggest that TDF should be part of an antiretroviral regimen in immunosuppressed patients at risk of anaemia. Keywords: HIV, Tenoforvir (TDF), CD4 and immunosuppressed
Abstract